Sponsor Deadline
Posted: 4/18/2022

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs

The National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for projects that address the COVID-19 Public Health Emergency. The Clinical and Translational Science Award (CTSA) Program is uniquely qualified to contribute to these efforts. NCATS is soliciting applications for Administrative Supplements (through PA-18-591) and Emergency Competitive Revisions (through PA-20-135) from current Clinical and Translational Science Award (CTSA) UL1 and U24 award recipients ​​​​​​.

Applications will be accepted immediately and on a rolling basis through November 10, 2020 by 5:00 PM local time of the applicant organization. This NOSI expires on November 11, 2020. An application submitted in response to this NOSI that is received on November 11, 2020 or later, will be withdrawn. Applications will be considered for funding in FY20 or FY21 pending: award timelines, availability of funds, and programmatic priority.

Amount Description

 

Funding Type
Eligibility
Posted
4/18/2022
Deadline
Sponsor: